GlobeNewswire: Invuity, Inc. Contains the last 10 of 59 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T08:01:29ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2018/09/11/1569100/0/en/Invuity-Announces-Definitive-Agreement-to-Be-Acquired-by-Stryker-Corporation-for-7-40-Per-Share-in-Cash.html?f=22&fvtc=4&fvtv=26694Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash2018-09-11T12:00:00Z<![CDATA[SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per share in cash, implying a total equity value of approximately $190 million.]]>https://www.globenewswire.com/news-release/2018/08/14/1551940/0/en/Invuity-Announces-Commercial-Launch-of-PhotonGuide-Adapt-for-Vaginal-Hysterectomy-and-Pelvic-Organ-Prolapse-Procedures.html?f=22&fvtc=4&fvtv=26694Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures2018-08-14T20:11:03Z<![CDATA[SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a novel system that consists of a flexible illuminator and a family of compatible retractors for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies.]]>https://www.globenewswire.com/news-release/2018/08/02/1546609/0/en/Invuity-Announces-2018-Second-Quarter-Six-Month-Financial-Results.html?f=22&fvtc=4&fvtv=26694Invuity Announces 2018 Second Quarter, Six-Month Financial Results2018-08-02T20:01:00Z<![CDATA[SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018.]]>https://www.globenewswire.com/news-release/2018/07/20/1540275/0/en/Invuity-Announces-2018-Second-Quarter-Financial-Results-and-Conference-Call-Date.html?f=22&fvtc=4&fvtv=26694Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date2018-07-20T20:01:00Z<![CDATA[SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter financial results after the market closes on Thursday, August 2, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Thursday, August 2, 2018, to discuss the financial results and other business developments.]]>https://www.globenewswire.com/news-release/2018/05/29/1513451/0/en/Invuity-to-Present-at-William-Blair-Annual-Growth-Stock-Conference.html?f=22&fvtc=4&fvtv=26694Invuity to Present at William Blair Annual Growth Stock Conference2018-05-29T20:01:00Z<![CDATA[SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at the 38th Annual Growth Stock Conference on Tuesday, June 12, 2018 at 9:30 a.m. Central Time in Chicago.]]>https://www.globenewswire.com/news-release/2018/05/14/1502103/0/en/Invuity-Announces-Results-of-New-PhotonBlade-Studies-at-2018-Heart-Rhythm-Society-Conference.html?f=22&fvtc=4&fvtv=26694Invuity Announces Results of New PhotonBlade® Studies at 2018 Heart Rhythm Society Conference2018-05-14T20:50:11Z<![CDATA[Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade]]>https://www.globenewswire.com/news-release/2018/05/03/1496326/0/en/Invuity-Announces-First-Quarter-Financial-Results.html?f=22&fvtc=4&fvtv=26694Invuity Announces First Quarter Financial Results2018-05-03T20:01:00Z<![CDATA[SAN FRANCISCO, May 03, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months ended March 31, 2018.]]>https://www.globenewswire.com/news-release/2018/04/19/1482125/0/en/Invuity-Announces-2018-First-Quarter-Financial-Results-and-Conference-Call-Date.html?f=22&fvtc=4&fvtv=26694Invuity Announces 2018 First Quarter Financial Results and Conference Call Date2018-04-19T20:01:00Z<![CDATA[SAN FRANCISCO, April 19, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 first quarter financial results after the market closes on Thursday, May 3, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Thursday, May 3, 2018, to discuss the financial results and other business developments.]]>https://www.globenewswire.com/news-release/2018/03/15/1438103/0/en/Invuity-Announces-Pricing-of-Public-Offering-of-Common-Stock.html?f=22&fvtc=4&fvtv=26694Invuity Announces Pricing of Public Offering of Common Stock 2018-03-15T13:47:06Z<![CDATA[SAN FRANCISCO, March 15, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) (“Invuity” or the “Company”), a leading medical technology company focused on minimal access surgery, today announced the pricing of its public offering of 6,200,000 shares of its common stock at a price to the public of $3.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of its common stock.]]>https://www.globenewswire.com/news-release/2018/03/14/1422722/0/en/Invuity-Announces-Proposed-Public-Offering-of-Common-Stock.html?f=22&fvtc=4&fvtv=26694Invuity Announces Proposed Public Offering of Common Stock2018-03-14T20:04:46Z<![CDATA[SAN FRANCISCO, March 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading medical technology company focused on minimal access surgery, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Invuity expects to grant the underwriters a 30-day option to purchase additional shares of its common stock.]]>